메뉴 건너뛰기
Movement Disorders
Volumn 28, Issue 12, 2013, Pages 1620-1621
Metabolomics and the search for biomarkers in Parkinson's disease
Author keywords

[No Author keywords available]
Indexed keywords

3 HYDROXYKYNURENINE; BIOLOGICAL MARKER; EXCITOTOXIN; MULTIENZYME COMPLEX;
EID: 84886442903     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25644     Document Type: Editorial
Times cited : (9)
References (12)
  • 1
    • 0035100888 scopus 로고    scopus 로고
    • Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
    • Biomarkers Definitions Working Group
    • Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95.
    • (2001) Clin Pharmacol Ther , vol.69 , pp. 89-95
  • 2
    • 67049134827 scopus 로고    scopus 로고
    • Metabolomics tools for identifying biomarkers for neuropsychiatric diseases
    • Quinones MP, Kaddurah-Daouk R. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 2009;35:165-176.
    • (2009) Neurobiol Dis , vol.35 , pp. 165-176
    • Quinones, M.P.1    Kaddurah-Daouk, R.2
  • 3
    • 84857633703 scopus 로고    scopus 로고
    • Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics
    • Gerlach M, Maetzler W, Broich K, et al. Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics. J Neural Transm 2012;119:39-52.
    • (2012) J Neural Transm , vol.119 , pp. 39-52
    • Gerlach, M.1    Maetzler, W.2    Broich, K.3
  • 4
    • 84886413067 scopus 로고    scopus 로고
    • 3-Hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
    • LeWitt PA, Li J, Lu M, et al. 3-Hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis. Mov Disord 2013; 28:1653-1660.
    • (2013) Mov Disord , vol.28 , pp. 1653-1660
    • LeWitt, P.A.1    Li, J.2    Lu, M.3
  • 5
    • 38849159145 scopus 로고    scopus 로고
    • Metabolomic profiling to develop blood biomarkers for Parkinson's disease
    • Bogdanov M, Matson WR, Wang L, et al. Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 2008;131(pt 2):389-396.
    • (2008) Brain , vol.131 , Issue.PART 2 , pp. 389-396
    • Bogdanov, M.1    Matson, W.R.2    Wang, L.3
  • 6
    • 70449552850 scopus 로고    scopus 로고
    • Metabolomic profiling in LRRK2-related Parkinson's disease [serial online]
    • Johansen KK, Wang L, Aasly JO, et al. Metabolomic profiling in LRRK2-related Parkinson's disease [serial online]. PLoS One 2009;4:e7551.
    • (2009) PLoS One , vol.4
    • Johansen, K.K.1    Wang, L.2    Aasly, J.O.3
  • 7
    • 84877127791 scopus 로고    scopus 로고
    • Coupling ultra high-pressure liquid chromatography with mass spectrometry: constraints and possible applications
    • Rodriguez-Aller M, Gurny R, Veuthey JL, Guillarme D. Coupling ultra high-pressure liquid chromatography with mass spectrometry: constraints and possible applications. J Chromatogr A 2013;1292:2-18.
    • (2013) J Chromatogr A , vol.1292 , pp. 2-18
    • Rodriguez-Aller, M.1    Gurny, R.2    Veuthey, J.L.3    Guillarme, D.4
  • 8
    • 84868107510 scopus 로고    scopus 로고
    • Dysregulation of glutathione homeostasis in neurodegenerative diseases
    • Johnson WM, Wilson-Delfosse AL, Mieyal JJ. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients 2012;4:1399-1440.
    • (2012) Nutrients , vol.4 , pp. 1399-1440
    • Johnson, W.M.1    Wilson-Delfosse, A.L.2    Mieyal, J.J.3
  • 9
    • 79951492876 scopus 로고    scopus 로고
    • Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases
    • Maetzler W, Schmid SP, Wurster I, et al. Reduced but not oxidized cerebrospinal fluid glutathione levels are lowered in Lewy body diseases. Mov Disord 2011;26:176-181.
    • (2011) Mov Disord , vol.26 , pp. 176-181
    • Maetzler, W.1    Schmid, S.P.2    Wurster, I.3
  • 10
    • 0026671306 scopus 로고
    • Kynurenine pathway abnormalities in Parkinson's disease
    • Ogawa T, Matson WR, Beal MF, et al. Kynurenine pathway abnormalities in Parkinson's disease. Neurology 1992;42:1702-1706.
    • (1992) Neurology , vol.42 , pp. 1702-1706
    • Ogawa, T.1    Matson, W.R.2    Beal, M.F.3
  • 11
    • 84859846991 scopus 로고    scopus 로고
    • Defining at-risk populations for Parkinson's disease: lessons from ongoing studies
    • Berg D, Marek K, Ross GW, Poewe W. Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Mov Disord 2012;27:656-665.
    • (2012) Mov Disord , vol.27 , pp. 656-665
    • Berg, D.1    Marek, K.2    Ross, G.W.3    Poewe, W.4
  • 12
    • 78649231863 scopus 로고    scopus 로고
    • Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities
    • Mellick GD, Silburn PA, Sutherland GT, Siebert GA. Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities. Expert Rev Mol Diagn 2010;10:1035-1050.
    • (2010) Expert Rev Mol Diagn , vol.10 , pp. 1035-1050
    • Mellick, G.D.1    Silburn, P.A.2    Sutherland, G.T.3    Siebert, G.A.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.